PMID- 15644117 OWN - NLM STAT- MEDLINE DCOM- 20050301 LR - 20220331 IS - 0300-9475 (Print) IS - 0300-9475 (Linking) VI - 61 IP - 1 DP - 2005 Jan TI - RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. PG - 1-9 AB - Abstract High-mobility group box chromosomal protein 1 (HMGB1) is a protein with both intranuclear functions and extracellular cytokine-like effects. In this report, we study possible candidate receptors for HMGB1 on macrophages (Mphi) and define pathways activated by HMGB1 binding. Bone marrow Mphi were prepared from Dark Agouti (DA) rats and stimulated in vitro with HMGB1. The kinetics of tumour necrosis factor (TNF) production, NO production, activation of p38 mitogen-activated protein kinase (MAPK), p44/42 MAPK- and SAPK/JNK-signalling pathways, nuclear translocation of nuclear factor kappa B (NF-kappaB) and HMGB1-induced upregulation of major histocompatibility complex (MHC) class II and CD86 were analysed. Mphi from interleukin (IL)-1 receptor type I-/-, Toll-like receptor 2 (TLR2-/-) and RAGE-/- mice were used to investigate the role of these receptors in HMGB1 signalling. HMGB1 induced TNF and NO production by Mphi, phosphorylation of all investigated MAP kinase pathways and NF-kappaB translocation, and expression of MHC class II was increased. Mphi from RAGE-/- mice produced significantly lower amounts of TNF, IL-1beta and IL-6, while IL-1RI-/- and TLR2-/- Mphi produced cytokine levels comparable with wildtype controls in response to HMGB1 stimulation. We conclude that HMGB1 has the potential to induce a proinflammatory phenotype in Mphi, with RAGE as the major activation-inducing receptor. FAU - Kokkola, R AU - Kokkola R AD - Department of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden. FAU - Andersson, A AU - Andersson A FAU - Mullins, G AU - Mullins G FAU - Ostberg, T AU - Ostberg T FAU - Treutiger, C-J AU - Treutiger CJ FAU - Arnold, B AU - Arnold B FAU - Nawroth, P AU - Nawroth P FAU - Andersson, U AU - Andersson U FAU - Harris, R A AU - Harris RA FAU - Harris, H E AU - Harris HE LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Scand J Immunol JT - Scandinavian journal of immunology JID - 0323767 RN - 0 (Cytokines) RN - 0 (HMGB1 Protein) RN - 0 (Hbp1 protein, rat) RN - 0 (High Mobility Group Proteins) RN - 0 (Histocompatibility Antigens Class II) RN - 0 (Inflammation Mediators) RN - 0 (NF-kappa B) RN - 0 (Receptor for Advanced Glycation End Products) RN - 0 (Receptors, Cell Surface) RN - 0 (Receptors, Immunologic) RN - 0 (Receptors, Interleukin-1) RN - 0 (Receptors, Interleukin-1 Type I) RN - 0 (Recombinant Proteins) RN - 0 (Repressor Proteins) RN - 0 (Tlr2 protein, mouse) RN - 0 (Toll-Like Receptor 2) RN - 0 (Tumor Necrosis Factor-alpha) RN - 31C4KY9ESH (Nitric Oxide) RN - EC 2.7.11.24 (Extracellular Signal-Regulated MAP Kinases) SB - IM MH - Animals MH - Cytokines/biosynthesis MH - Extracellular Signal-Regulated MAP Kinases/metabolism MH - Female MH - HMGB1 Protein/metabolism MH - High Mobility Group Proteins/metabolism/*pharmacology MH - Histocompatibility Antigens Class II/metabolism MH - In Vitro Techniques MH - Inflammation Mediators/*metabolism/pharmacology MH - Macrophage Activation/drug effects MH - Macrophages/*drug effects/immunology/*metabolism MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - NF-kappa B/metabolism MH - Nitric Oxide/biosynthesis MH - Phosphorylation MH - Rats MH - Receptor for Advanced Glycation End Products MH - Receptors, Cell Surface/deficiency/genetics/metabolism MH - Receptors, Immunologic MH - Receptors, Interleukin-1/deficiency/genetics/metabolism MH - Receptors, Interleukin-1 Type I MH - Recombinant Proteins/metabolism/pharmacology MH - Repressor Proteins/metabolism/*pharmacology MH - Toll-Like Receptor 2 MH - Tumor Necrosis Factor-alpha/biosynthesis EDAT- 2005/01/13 09:00 MHDA- 2005/03/02 09:00 CRDT- 2005/01/13 09:00 PHST- 2005/01/13 09:00 [pubmed] PHST- 2005/03/02 09:00 [medline] PHST- 2005/01/13 09:00 [entrez] AID - SJI1534 [pii] AID - 10.1111/j.0300-9475.2005.01534.x [doi] PST - ppublish SO - Scand J Immunol. 2005 Jan;61(1):1-9. doi: 10.1111/j.0300-9475.2005.01534.x.